Replies to post #208996 on Biotech Values

[jq1234]

>> So looking at 500M+ opportunity for US and putting no value on everything else (Europe, x-EU/US, pipeline) the company is 2x peek US only sales which I think they can get too relatively soon (~2-3 years).

That sounds extremely optimistic to me.